Febrile neutropenia, a severe complication for patients with blood cancers undergoing chemotherapy, is a major concern. This study explored whether Channa striata, a freshwater fish, could help. The goal was to see if extracts from this fish could boost the body's neutrophil count and function, and perhaps even prevent febrile neutropenia in patients with acute myeloid leukemia (AML) receiving chemotherapy.

Channa striata belongs to the Channidae family and has been studied for its potential health benefits. The research was designed as a randomized controlled trial to ensure accurate results. The study aimed to determine if administering Channa striata extract could make a difference in treating AML patients.

The focus was on neutrophils, a type of white blood cell crucial for fighting infections. Chemotherapy often leads to a drop in neutrophil count, making patients more susceptible to infections. By exploring the effect of Channa striata extract, the study hoped to find a natural way to combat this issue.

The study was meticulous in its approach, carefully measuring the neutrophil count and function in patients who received the extract compared to those who did not. The goal was to provide evidence-based insights into whether this fish extract could be a viable supplement in cancer treatment.

Fish Extracts in Cancer Treatment: A Closer Look

Actions